Spots Global Cancer Trial Database for metastatic malignant neoplasm in the bone
Every month we try and update this database with for metastatic malignant neoplasm in the bone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases | NCT00936975 | Hormone-Resista... Metastatic Mali... Recurrent Prost... Stage IV Prosta... | Fluorine F 18 S... | 18 Years - | National Cancer Institute (NCI) | |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer | NCT03796767 | Recurrent Prost... Metastatic Mali... Metastatic Mali... Oligometastasis Prostate Adenoc... PSA Failure | Hypofractionate... Intensity-Modul... Metastasectomy Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | University of Utah | |
| Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer | NCT04754425 | Castration-Resi... Castration-Resi... Metastatic Mali... Metastatic Pros... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Biopsy Biospecimen Col... Erdafitinib | 18 Years - | M.D. Anderson Cancer Center | |
| Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy | NCT02099864 | Castration-Resi... Metastatic Mali... Metastatic Mali... Metastatic Pros... Recurrent Prost... Stage III Prost... Stage IV Prosta... | Enzalutamide | 18 Years - | OHSU Knight Cancer Institute | |
| Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer | NCT03649841 | Castration-Sens... Metastatic Mali... Metastatic Pros... Prostate Adenoc... Prostate Small ... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Antiandrogen Th... Abiraterone Ace... Prednisone Radiation Thera... | 18 Years - | University of Washington | |
| Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study | NCT03793166 | Clear Cell Rena... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Mali... Sarcomatoid Ren... Stage III Renal... Stage IV Renal ... | Biospecimen Col... Cabozantinib Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Quality-of-Life... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | NCT02565901 | Castration-Resi... Metastatic Pros... Stage IV Prosta... Metastatic Mali... | Carboplatin Docetaxel Laboratory Biom... Sirolimus | 18 Years - | University of Washington | |
| Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | NCT02565901 | Castration-Resi... Metastatic Pros... Stage IV Prosta... Metastatic Mali... | Carboplatin Docetaxel Laboratory Biom... Sirolimus | 18 Years - | University of Washington | |
| Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones | NCT04616547 | Castration-Resi... Metastatic Mali... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Questionnaire A... Tin Sn 117m Pen... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T | NCT01833208 | Hormone-Resista... Metastatic Mali... Recurrent Prost... Stage IV Prosta... | Laboratory Biom... Radiation Thera... | 18 Years - | Roswell Park Cancer Institute | |
| Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones | NCT04090398 | Anatomic Stage ... Metastatic HER2... Metastatic Mali... | Biospecimen Col... Bone Scan Computed Tomogr... Electronic Heal... Magnetic Resona... Paclitaxel Radium Ra 223 D... Single Photon E... | 18 Years - | National Cancer Institute (NCI) | |
| Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis | NCT02699697 | Malignant Neopl... Metastatic Mali... Pain | External Beam R... Palliative Radi... Quality-of-Life... Questionnaire A... | - | Wake Forest University Health Sciences | |
| Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | NCT01050504 | Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta... | Cytology Specim... Laboratory Biom... | 18 Years - | University of Washington | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones | NCT04090398 | Anatomic Stage ... Metastatic HER2... Metastatic Mali... | Biospecimen Col... Bone Scan Computed Tomogr... Electronic Heal... Magnetic Resona... Paclitaxel Radium Ra 223 D... Single Photon E... | 18 Years - | National Cancer Institute (NCI) | |
| Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer | NCT03649841 | Castration-Sens... Metastatic Mali... Metastatic Pros... Prostate Adenoc... Prostate Small ... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Antiandrogen Th... Abiraterone Ace... Prednisone Radiation Thera... | 18 Years - | University of Washington | |
| BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors | NCT05010096 | Locally Advance... Metastatic Mali... Metastatic Mali... Recurrent Malig... | Copanlisib Elimusertib | 18 Years - | M.D. Anderson Cancer Center | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery | NCT05174026 | Metastatic Mali... Metastatic Mali... | Fludeoxyglucose... Magnetic Resona... Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma | NCT02306161 | Metastatic Ewin... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Peri... Peripheral Prim... | Cyclophosphamid... Doxorubicin Doxorubicin Hyd... Etoposide Etoposide Phosp... External Beam R... Ganitumab Ifosfamide Stereotactic Ra... Therapeutic Sur... Vincristine Vincristine Sul... | - 50 Years | National Cancer Institute (NCI) | |
| BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors | NCT05010096 | Locally Advance... Metastatic Mali... Metastatic Mali... Recurrent Malig... | Copanlisib Elimusertib | 18 Years - | M.D. Anderson Cancer Center | |
| Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma | NCT03858205 | Bone Pain Metastatic Mali... Plasma Cell Mye... | Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | University of Southern California | |
| Efficacy of Ra-223 in PSMA PET Optimally Selected Patients | NCT05924672 | Castration-Resi... Metastatic Mali... Stage IVB Prost... | Radium-223 PSMA Positron E... Technetium Tc 9... | 18 Years - | University of California, San Francisco | |
| 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy | NCT04928820 | Biochemically R... Metastatic Mali... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Efficacy of Ra-223 in PSMA PET Optimally Selected Patients | NCT05924672 | Castration-Resi... Metastatic Mali... Stage IVB Prost... | Radium-223 PSMA Positron E... Technetium Tc 9... | 18 Years - | University of California, San Francisco | |
| Efficacy of Ra-223 in PSMA PET Optimally Selected Patients | NCT05924672 | Castration-Resi... Metastatic Mali... Stage IVB Prost... | Radium-223 PSMA Positron E... Technetium Tc 9... | 18 Years - | University of California, San Francisco | |
| Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma | NCT02306161 | Metastatic Ewin... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Peri... Peripheral Prim... | Cyclophosphamid... Doxorubicin Doxorubicin Hyd... Etoposide Etoposide Phosp... External Beam R... Ganitumab Ifosfamide Stereotactic Ra... Therapeutic Sur... Vincristine Vincristine Sul... | - 50 Years | National Cancer Institute (NCI) | |
| Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal Metastases | NCT02715856 | Bone Metastases Cancer Survivor Metastatic Mali... | Monitoring Devi... Physical Activi... Quality-of-Life... Questionnaire A... Standard Follow... Survey Administ... | 18 Years - | M.D. Anderson Cancer Center | |
| Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | NCT02565901 | Castration-Resi... Metastatic Pros... Stage IV Prosta... Metastatic Mali... | Carboplatin Docetaxel Laboratory Biom... Sirolimus | 18 Years - | University of Washington | |
| Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases | NCT00936975 | Hormone-Resista... Metastatic Mali... Recurrent Prost... Stage IV Prosta... | Fluorine F 18 S... | 18 Years - | National Cancer Institute (NCI) | |
| Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | NCT01050504 | Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta... | Cytology Specim... Laboratory Biom... | 18 Years - | University of Washington | |
| Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | NCT01050504 | Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta... | Cytology Specim... Laboratory Biom... | 18 Years - | University of Washington | |
| Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer | NCT03012230 | Metastatic Mali... Stage IV Breast... Triple-Negative... | Laboratory Biom... Pembrolizumab Ruxolitinib Pho... | 18 Years - | Mayo Clinic | |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer | NCT02499835 | Hormone-Resista... Metastatic Mali... Metastatic Mali... Metastatic Pros... Prostate Adenoc... Recurrent Prost... Stage IV Prosta... | Pembrolizumab pTVG-HP Plasmid... | 18 Years - | University of Wisconsin, Madison | |
| Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial | NCT04693377 | Castration-Resi... Metastatic Colo... Metastatic Mali... Metastatic Mali... Metastatic Mela... Metastatic Pros... Metastatic Rena... Metastatic Sarc... Metastatic Thyr... Metastatic Urot... Stage IV Colore... Stage IV Prosta... Stage IV Renal ... Stage IVA Color... Stage IVA Prost... Stage IVB Color... Stage IVB Prost... Stage IVC Color... | Cryosurgery Quality-of-Life... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma | NCT03858205 | Bone Pain Metastatic Mali... Plasma Cell Mye... | Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | University of Southern California | |
| Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer | NCT03204812 | Castration-Resi... Metastatic Mali... Prostate Adenoc... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Durvalumab Tremelimumab | 18 Years - | M.D. Anderson Cancer Center | |
| Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival | NCT02364557 | Anatomic Stage ... Metastatic Brea... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Mali... Prognostic Stag... Anatomic Stage ... | Stereotactic Bo... Surgery | 18 Years - | NRG Oncology | |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer | NCT03796767 | Recurrent Prost... Metastatic Mali... Metastatic Mali... Oligometastasis Prostate Adenoc... PSA Failure | Hypofractionate... Intensity-Modul... Metastasectomy Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | University of Utah | |
| Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study | NCT04071223 | Advanced Renal ... Chromophobe Ren... Clear Cell Rena... Collecting Duct... Kidney Medullar... Metastatic Mali... Papillary Renal... Stage IV Renal ... Unclassified Re... | Cabozantinib S-... Quality-of-Life... Questionnaire A... Radium Ra 223 D... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
